Lusutrombopag

(Mulpleta)

Lusutrombopag

Drug updated on 11/16/2023

Dosage FormTablet (oral; 3 mg)
Drug ClassThrombopoietin receptor agonists
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.